These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 21389673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
    Tongsong T, Piyamongkol W, Tongprasert F, Srisupundit K, Luewan S.
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
    Srisupundit K, Piyamongkol W, Tongsong T.
    Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
    Thathan N, Traisrisilp K, Luewan S, Srisupundit K, Tongprasert F, Tongsong T.
    BMC Pregnancy Childbirth; 2014 Jul 16; 14():230. PubMed ID: 25028081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
    Tongsong T, Wanapirak C, Sirichotiyakul S.
    Prenat Diagn; 1999 Nov 16; 19(11):1027-30. PubMed ID: 10589053
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy.
    Tongprasert F, Wanapirak C, Tongsong T.
    Prenat Diagn; 2011 May 16; 31(5):430-3. PubMed ID: 21312197
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
    Tongprasert F, Srisupundit K, Luewan S, Tongsong T.
    J Matern Fetal Neonatal Med; 2013 Jan 16; 26(2):146-9. PubMed ID: 22989193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation.
    Sirichotiyakul S, Luewan S, Srisupundit K, Tongprasert F, Tongsong T.
    Prenat Diagn; 2014 Mar 16; 34(3):230-4. PubMed ID: 24318930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.